STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

ETRADE Form 144 Notice: Proposed Sale of 3,731 Shares Valued $417.9K

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Form 144 notice reports a proposed sale of 3,731 shares of common stock of ETRADE FINANCIAL CORPORATION on NASDAQ with an aggregate market value of $417,872 and 60,658,809 shares outstanding. The securities were acquired on 08/07/2025 through restricted stock vesting from the issuer and the reported payment/nature is compensation. The proposed sale date is 08/08/2025. The filer reports no securities sold in the past three months and the filing is marked LIVE. The form includes the standard representation that the seller does not possess undisclosed material adverse information and references trading-plan/Rule 10b5-1 considerations.

Positive

  • None.

Negative

  • None.

Insights

TL;DR: The proposed sale is immaterial to capitalization; value is $417,872 and represents ~0.0062% of outstanding shares.

The filing discloses a small, routine proposed sale of 3,731 shares valued at $417,872 against 60,658,809 shares outstanding, implying a negligible impact on market supply or company ownership. The shares were issued via restricted stock vesting the day before sale, and no prior sales in the past three months are reported. For investors, this is a compliance disclosure rather than a material corporate development.

TL;DR: Form 144 is a routine Rule 144 disclosure confirming proposed sale and the seller's representation about lack of undisclosed material information.

The document follows Rule 144 mechanics: it identifies the class, broker, proposed sale date, acquisition method (restricted stock vesting), and contains the sellers certification about material nonpublic information. It also notes the option for trading-plan/Rule 10b5-1 adoption language. There are no red flags such as large block sales, prior three-month sales, or unusual consideration terms disclosed.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What securities are being offered for sale in this Form 144?

3,731 shares of common stock of ETRADE FINANCIAL CORPORATION are proposed for sale.

When is the proposed sale date and on which exchange will it occur?

Proposed sale date: 08/08/2025; Exchange: NASDAQ.

How were the shares acquired and when were they paid for?

Acquisition: Restricted stock vesting from the issuer on 08/07/2025; Nature of payment: Compensation on 08/07/2025.

What is the aggregate market value and how many shares are outstanding?

Aggregate market value: $417,872; Shares outstanding: 60,658,809.

Were any securities of the issuer sold by this person in the past three months?

No. The filer reports Nothing to Report for securities sold in the past three months.
Jazz Pharmaceuticals Plc

NASDAQ:JAZZ

JAZZ Rankings

JAZZ Latest News

JAZZ Latest SEC Filings

JAZZ Stock Data

10.02B
58.92M
3.11%
105.97%
9.42%
Biotechnology
Pharmaceutical Preparations
Link
Ireland
DUBLIN